The effects of alpha-tocopherol on critical cells in atherogenesis

Current Opinion in Lipidology

Volumn 9, Issue 1, 1998, Pages 11-15

  Devaraj, S ^a,b   Jialal, I ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ARTERIOSCLEROSIS; BLOOD PLATELETS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; VITAMIN E;

EID: 0031972958     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199802000-00004     Document Type: Article

References (29)

1. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage. Annu Rev Biochem 1983; 52:223.
2. Jialal I, Devaraj S. Low density lipoprotein oxidation, antioxidants and atherosclerosis: A clinical biochemistry perspective. Clin Chem 1996; 42:498-506.
3. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-416.
4. Stephens SG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347:781-786.
5. Belcher JD, Balla J, Balla G, Jacobs DR Jr, Gross M, Jacob HS, et al. Vitamin E, LDL and endothelium: brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler Thromb 1993; 13:1779-1789.
6. Devaraj S, Huet B, Fuller C, Jialal I. A dose response comparison of RRR-alpha-tocopherol and all-rac-alpha-tocopherol on LDL oxidation. Arterioscler Thromb Vasc Biol 1997; 17:2273-2279.
7. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol: role of protein kinase C. J Biol Chem 1991; 266:6188-6194.
8. Azzi A, Boscoboinik D, Marilley D, Ozer NK, Stauble B, Tasinato A. Vitamin E: a sensor and information transducer of the cell oxidation state. Am J Clin Nutr 1995; 62 (Suppl):1337-1346.
9. Kunisaki M, Bursell S, Umeda F, Nawata H, King GL. Normalization of DAG-PKC activation by vitamin E in aorta of diabetic rats and cultures rat SMC exposed to elevated glucose levels. Diabetes 1994; 42:1372-1377.
10. DeMaio SJ, King SB, Lembo MJ, Roubin GS, Hearn JA, Bhagavan HN, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after PTCA. J AM Coll Nutr 1992; 11:68-73.
11. LaFont AM, Chai YC, Cornhill JF, Whitlow PL, Howe PH, Chisolm GM. Effect of AT on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest 1995; 95:1018-1025.
12. Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL. Inhibition of IL-1β expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 1991; 86:161-170.
13. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function-decreased lipid oxidation, IL-1β secretion and monocyte adhesion to endothelium. J Clin Invest 1996; 98:756-763. This study provides novel evidence for an intracellular effect of alpha tocopherol in monocytes that is anti-atherogenic, such as the inhibition of lipid oxidation, cytokine release and decreased monocyte-endothelial cell adhesion following alpha tocopherol supplementation.
14. Devaraj S, Jialal I. Alpha tocopherol inhibits IL-1β from human monocytes [Abstract]. FASEB J 1997; 11:3753.
15. Meydani SN, Barklund P, Liu S, Meydani M, Miller RA, Cannon JG, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr 1990; 52:557-563.
16. Hennig B, Toborek M, McClain CJ, Diana JN. Nutritional implications in vascular endothelial cell metabolism. J Am Coll Nutr 1996; 15:345-358.
17. Kunisaki M, Umeda F, Inoguchi T, Navata H. Vitamin E restores reduced prostacyclin synthesis in aortic endothelial cells cultured with a high concentration of glucose. Metabolism 1992; 41:613-621.
18. Faruqui R, Motte C, DiCorleto PE. AT inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94:592-600.
19. Martin A, Foxald T, Blumberg JB, Meydani M. AT inhibits LDL-induced adhesion of monocytes to HAEC in vitro. Arterioscler Thromb Vasc Biol 1997; 17:429-436. Findings indicate that alpha tocopherol has an inhibitory effect on LDL-induced adhesion of monocytes to endothelial cells and on the expression of soluble intercellular adhesion molecule-1.
20. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Davoli A, et al. Antioxidants inhibit expression of ICAM-1 and VCAM-1 induced by oxidized LDL on HUVEC. Free Rad Biol and Med 1997; 22:117-127.
21. Keaney JF, Gaziano M, Xu A, Frei B, Schwaery GT, Loscalzo J, et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 1993; 90:11880-11884.
22. Stewart Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Anggard EE. Vtamin E protects against impairment of endothelium-mediated relaxation in cholesterol-fed rabbits. Arterioscler Thromb 1994; 14:494-499.
23. Keaney JF, Guo Y, Cunningham D, Schwaery GT, Xu A, Vita JA. Vascular incorporation of AT prevents endothelial dysfunction due to Ox-LDL by inhibiting PKC stimulation. J Clin Invest 1996; 98:386-394. This study shows that enrichment of vascular tissue with alpha tocopherol protects the vascular endothelium from Ox-LDL mediated dysfunction through inhibition of PKC.
24. Traber MG, Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr 1995; 62 (Suppl):1501-1509.
25. Suzuki YZ, Packer L. Inhibition of NFKb activation by vitamin E derivatives. Biochem Biophys Res Commun 1993; 193:277-283.
26. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 1991; 10:466-473.
27. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 1995; 62 (Suppl):1382-1384.
28. Freedman JE, Farhat JH, Loscalzo J, Keaney JF. AT inhibits platelet aggregation by a PKC-dependent mechanism. Circulation 1996; 94:2434-2440. This paper shows that inhibition of platelet aggregation by alpha tocopherol is mediated by inhibition of PKC.
29. Dowd P, Zheng ZB. On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci USA 1995; 92:8171-8175.